Mesoblast (MESO) Gains from Investment Securities (2016 - 2024)
Historic Gains from Investment Securities for Mesoblast (MESO) over the last 9 years, with Q4 2024 value amounting to -$779000.0.
- Mesoblast's Gains from Investment Securities fell 33115.73% to -$779000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$779000.0, marking a year-over-year increase of 7231.7%. This contributed to the annual value of $337000.0 for FY2024, which is 10562.7% up from last year.
- Per Mesoblast's latest filing, its Gains from Investment Securities stood at -$779000.0 for Q4 2024, which was down 33115.73% from $337000.0 recorded in Q2 2024.
- In the past 5 years, Mesoblast's Gains from Investment Securities registered a high of $15.1 million during Q3 2020, and its lowest value of -$18.1 million during Q1 2021.
- For the 5-year period, Mesoblast's Gains from Investment Securities averaged around -$1.3 million, with its median value being $337000.0 (2023).
- Per our database at Business Quant, Mesoblast's Gains from Investment Securities surged by 534548.61% in 2020 and then crashed by 149571.43% in 2022.
- Mesoblast's Gains from Investment Securities (Quarter) stood at $1.5 million in 2020, then skyrocketed by 47.2% to $2.2 million in 2021, then fell by 29.37% to $1.5 million in 2022, then tumbled by 77.83% to $337000.0 in 2023, then crashed by 331.16% to -$779000.0 in 2024.
- Its Gains from Investment Securities stands at -$779000.0 for Q4 2024, versus $337000.0 for Q2 2024 and $337000.0 for Q4 2023.